Biotechnology atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Cannabis Study Finds Unsafe Levels Of Toxic Metals In Commercially Available Cannabis Rolling Papers Read more
Biotechnology Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter – Corcept Therapeutics (NASDAQ:CORT) Read more
Biotechnology Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study – Cerevel Therapeutics Hldg (NASDAQ:CERE) Read more
Biotechnology Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study Read more
Biotechnology Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data Why Is Palatin Technologies Stock Soaring On Monday? – Palatin Techs (AMEX:PTN) Read more
Cannabis Psychedelics Reform Update: Missouri’s $10M Budget, Maine’s & Maryland’s Study Groups, Oregon’s Re-Crim And More Read more
Biotechnology Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Pfizer’s Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study – Pfizer (NYSE:PFE) Read more